Literature DB >> 8646467

Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins.

K W Dawes1, C W Hanke.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans is an uncommon malignant tumor of the skin with a frequent tendency to recur after standard surgical excision. This study assesses the degree of subclinical tumor extension and evaluates the cure rate and tissue conservation abilities of Mohs micrographic surgery.
METHODS: Twenty-four patients with dermatofibrosarcoma protuberans underwent Mohs micrographic surgery. Surgical margins and clinical outcome were evaluated and compared with the results of standard surgical treatment in the medical literature.
RESULTS: Twenty-six Mohs micrographic surgical procedures were performed on 24 patients. Eighty-five percent of the procedures were microscopically cleared with 2.5-cm margins, 69% with 2.0-cm margins, 50% with 1.5-cm margins, and 35% with 1.0-cm margins. Two tumors would have been inadequately excised if standard 3-cm had been used. The assessment of tissue conservation revealed a mean of 43.0 cm(2) of tissue spared in a subset of seven tumors in functionally or cosmetically critical locations. Two tumors were recurrent following MMS and are detailed as case reports.
CONCLUSION: The variability of subclinical tumor extension in dermatofibrosarcoma protuberans is confirmed. The ability of Mohs micrographic surgery to minimize surgical margins, preserve cosmetically and functionally vital tissue, and yield high cure rates is confirmed.

Entities:  

Mesh:

Year:  1996        PMID: 8646467

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  Dermatofibrosarcoma Protuberans Male Breast: A Case report.

Authors:  Tahir Iqbal Mirza; Kaleem Akhtar; Hussan Burair Abbas; Mubashra Sameena; Fasiha Tahir; Saleem Khan; Akeel Ur Rehman Bhutto
Journal:  Oman Med J       Date:  2011-09

2.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

3.  Abdominoplasty and thoraco-epigastric flaps for large anterior trunk defects after dermatofibrosarcoma protuberans wide resection: Two illustrative cases.

Authors:  Diogo Casal; Nuno Fradinho; Luísa Ramos; João Ferreira; Alice Varanda; Cláudia Diogo; José Baltazar; Mário Fernandes; Carlos Correia; Maria-Angélica Almeida
Journal:  Int J Surg Case Rep       Date:  2012-11-10

Review 4.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

5.  Wide Local Excision for Dermatofibrosarcoma Protuberans: A Single-Center Series of 90 Patients.

Authors:  Byung Jun Kim; Hyeonwoo Kim; Ung Sik Jin; Kyung Won Minn; Hak Chang
Journal:  Biomed Res Int       Date:  2015-11-25       Impact factor: 3.411

Review 6.  Dermatofibrosarcoma protuberans treated by micrographic surgery.

Authors:  A Ah-Weng; J R Marsden; D S A Sanders; R Waters
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.